The heart is one of the first organ to form during development of the body. Each year cardiovascular diseases (CVD) are the most common cause of the deaths in Europe and the world. Statistics on cardiovascular diseases show that they are the leading cause of death in the EU, resulting mainly in heart attacks and strokes. The heart cells can’t heal itself unlike the other organ parts of the body. Cardiomyocytes face challenges to use for many novel applications but the research implementation on cardiomyocytes is limited.

Human cardiomyocytes derived from iPS cells are ideal to fulfill their potential in cardiotoxicity testing, high-throughput drug screening, metabolism analysis and electrophysiology as well as model of the human modeling of cardiac diseases.